This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Educational Activity

Monitoring Pharmacotherapy Response, Safety, and Tolerability to Enhance Adherence in Bipolar Disorder

Paul E. Keck, Jr., MD

Published: May 15, 2014

This CME activity is expired. For more CME activities, visit
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

Article Abstract

Among patients with bipolar disorder, treatment nonadherence can be triggered by lack of response or by medication-induced adverse effects. To track treatment response, clinicians can have patients complete daily life and mood charts to provide accurate information over time on patients’ mood, adherence, side effects, and life events. Rating scales like the CGI-BP are also an option for assessing treatment response. In addition, clinicians should monitor patients for common side effects related to bipolar depression treatments, such as sedation and weight gain/metabolic abnormalities, which lead to increased medical problems and shortened life expectancy. By implementing specific interventions to address these effects, clinicians can help promote optimal outcomes for patients with bipolar disorder.

Related Articles

Volume: 75

Quick Links: